UA107473C2 - Конденсовані тіазоло- та оксазолопіримідинони - Google Patents

Конденсовані тіазоло- та оксазолопіримідинони

Info

Publication number
UA107473C2
UA107473C2 UAA201205825A UAA201205825A UA107473C2 UA 107473 C2 UA107473 C2 UA 107473C2 UA A201205825 A UAA201205825 A UA A201205825A UA A201205825 A UAA201205825 A UA A201205825A UA 107473 C2 UA107473 C2 UA 107473C2
Authority
UA
Ukraine
Prior art keywords
oksazolopirimidinony
thiazolo
condensed
compounds
pharmaceutically acceptable
Prior art date
Application number
UAA201205825A
Other languages
English (en)
Russian (ru)
Inventor
Sanjay Srivastava
Laxmikant Chhipa
Ramesh Chandra Gupta
Shailesh Deshpande
Anita Chaudhary
Anookh Mohanan
Chaitanya Dutt
Vijay Chauthaiwale
Murali Badanthadka
Prashant G Jamadarkhana
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Publication of UA107473C2 publication Critical patent/UA107473C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/16—Peri-condensed systems

Abstract

Даний винахід також включає фармацевтично прийнятні композиції зазначених сполук і спосіб приготування нових сполук.
UAA201205825A 2009-10-13 2010-08-31 Конденсовані тіазоло- та оксазолопіримідинони UA107473C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1249KO2009 2009-10-13
PCT/IN2010/000579 WO2011045811A1 (en) 2009-10-13 2010-08-31 Fused thiazolo and oxazolo pyrimidinones

Publications (1)

Publication Number Publication Date
UA107473C2 true UA107473C2 (uk) 2015-01-12

Family

ID=43034589

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201205825A UA107473C2 (uk) 2009-10-13 2010-08-31 Конденсовані тіазоло- та оксазолопіримідинони

Country Status (27)

Country Link
EP (1) EP2385948B1 (uk)
JP (1) JP5681195B2 (uk)
KR (1) KR101710430B1 (uk)
CN (1) CN102549000B (uk)
AR (1) AR080616A1 (uk)
AU (1) AU2010307984B2 (uk)
BR (1) BR112012006233B8 (uk)
CA (1) CA2772995C (uk)
CY (1) CY1119710T1 (uk)
DK (1) DK2385948T3 (uk)
EA (1) EA020228B1 (uk)
ES (1) ES2653931T3 (uk)
HR (1) HRP20171976T1 (uk)
HU (1) HUE038051T2 (uk)
IL (1) IL219116A (uk)
LT (1) LT2385948T (uk)
MX (1) MX2012004074A (uk)
MY (1) MY157629A (uk)
NO (1) NO2385948T3 (uk)
NZ (1) NZ598020A (uk)
PL (1) PL2385948T3 (uk)
RS (1) RS56630B1 (uk)
SI (1) SI2385948T1 (uk)
TW (1) TWI500623B (uk)
UA (1) UA107473C2 (uk)
WO (1) WO2011045811A1 (uk)
ZA (1) ZA201203262B (uk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI661828B (zh) 2013-05-14 2019-06-11 印度商托仁特生技有限公司 低劑量藥物組合物及其用途
ES2898476T3 (es) 2014-09-02 2022-03-07 Sunshine Lake Pharma Co Ltd Compuesto de quinolona y uso del mismo
CN106905348B (zh) * 2017-02-13 2018-12-04 牡丹江医学院 一种预防和治疗急性肾损伤的药物及其制备方法和用途
CN110511233B (zh) * 2019-08-08 2022-01-25 成都大学 一种噻唑并[2,3-b]噁唑酮类化合物及其制备方法和用途
CN112778333B (zh) * 2021-01-23 2022-07-05 中国科学院新疆理化技术研究所 一种四氢噁唑并吡啶并氮氧杂酮类衍生物及其用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072679A (en) * 1976-06-15 1978-02-07 E. R. Squibb & Sons, Inc. 1,4- AND 4,10-DIHYDRO-4-OXO-PYRIMIDO (1,2-A)-benzimidazole-3-carboxylic acids, esters and amides
US4423048A (en) 1979-11-23 1983-12-27 Pfizer Inc. Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
DK151811C (da) * 1979-11-23 1988-06-06 Pfizer Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-1-oxo-1h-thiazolooe3,2-aaa-pyrimidin-2-carboxamider eller farmaceutisk acceptable kationsalte deraf samt 1-oxo-1h-thiazolooe3,2-aaapyrimidin-2-carboxylsyrer til anvendelse som udgangsmaterialer ved fremgangsmaaden
JPH0539293A (ja) * 1991-01-23 1993-02-19 Kyowa Hakko Kogyo Co Ltd 免疫調節剤及びチアゾロピリミジン誘導体
TW406076B (en) 1993-12-30 2000-09-21 Hoechst Ag Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
EP2324834B1 (en) 2001-12-06 2019-05-08 Fibrogen, Inc. Methods of Increasing Endogenous Erythropoietin (EPO)
CA2511493A1 (en) 2002-12-25 2004-07-15 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
JP5111491B2 (ja) * 2006-04-04 2013-01-09 フィブロジェン， インコーポレイテッド ピロロ−およびピラゾロ−ピリミジン化合物、およびそれらの使用方法
US7713986B2 (en) 2006-06-15 2010-05-11 Fibrogen, Inc. Compounds and methods for treatment of chemotherapy-induced anemia
US20070293575A1 (en) 2006-06-15 2007-12-20 Fibrogen, Inc. Compounds and methods for treatment of cancer-related anemia
TWI394747B (zh) * 2006-06-23 2013-05-01 Smithkline Beecham Corp 脯胺醯基羥化酶抑制劑
WO2009039321A1 (en) * 2007-09-19 2009-03-26 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors
WO2009039322A1 (en) * 2007-09-19 2009-03-26 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors

Also Published As

Publication number Publication date
KR20120093907A (ko) 2012-08-23
JP5681195B2 (ja) 2015-03-04
DK2385948T3 (en) 2017-12-04
EA201270556A1 (ru) 2013-01-30
AU2010307984A1 (en) 2012-03-01
PL2385948T3 (pl) 2018-02-28
HRP20171976T1 (hr) 2018-02-09
AU2010307984B2 (en) 2013-11-07
CN102549000A (zh) 2012-07-04
MY157629A (en) 2016-07-15
HUE038051T2 (hu) 2018-10-29
CN102549000B (zh) 2015-12-02
NO2385948T3 (uk) 2018-03-03
SI2385948T1 (en) 2018-04-30
EP2385948B1 (en) 2017-10-04
EA020228B1 (ru) 2014-09-30
CA2772995C (en) 2018-03-13
LT2385948T (lt) 2018-01-10
BR112012006233B8 (pt) 2021-05-25
CY1119710T1 (el) 2018-06-27
BR112012006233B1 (pt) 2021-05-18
JP2013507435A (ja) 2013-03-04
WO2011045811A1 (en) 2011-04-21
NZ598020A (en) 2013-11-29
KR101710430B1 (ko) 2017-02-27
EP2385948A1 (en) 2011-11-16
MX2012004074A (es) 2012-05-22
TW201113290A (en) 2011-04-16
BR112012006233A2 (pt) 2020-08-11
TWI500623B (zh) 2015-09-21
IL219116A0 (en) 2012-06-28
ZA201203262B (en) 2013-01-30
ES2653931T3 (es) 2018-02-09
AR080616A1 (es) 2012-04-25
CA2772995A1 (en) 2011-04-21
RS56630B1 (sr) 2018-03-30
IL219116A (en) 2016-05-31

Similar Documents

Publication Publication Date Title
EA201490807A1 (ru) Новые замещенные имидазопиримидины как модуляторы рецептора gpbar1
UA104489C2 (uk) Сполуки для лікування дисліпідемії та споріднених хвороб
MX2012002997A (es) Derivados de eter de los heteroarilos biciclicos.
MY157017A (en) Sulfonamide derivatives
WO2010092090A3 (en) Novel salts of sitagliptin
MY175854A (en) Novel quinolone derivatives
MX353209B (es) Antagonistas d2, metodos de sintesis y metodos de uso.
MX351305B (es) Antagonistas del receptor de mineralocorticoides.
TN2012000534A1 (en) Pyrazole compounds as sigma receptor inhibitors
IN2012DN03182A (uk)
PH12016501903B1 (en) Novel fused imidazobenzothiazole compounds
WO2012135615A3 (en) Enopeptins, uses thereof, and methods of synthesis thereto
PH12017501830A1 (en) Novel pyridinium compounds
CY1119710T1 (el) Συντηγμενες θειαζολο- και οξαζολο-πυριμιδινονες
MY161749A (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
PH12014501943A1 (en) Novel compounds for the treatment of dyslipidemia and related diseases
MX2013006768A (es) Moduladores de receptor de glucagon.
WO2010079045A3 (en) Crystalline salt forms of flibanserine
MX2012002608A (es) Compuesto 1,2-dihidro -2-oxoquinolona como ligandos del receptor 5ht4.
MX2012007783A (es) Compuestos sulfona que actuan como ligandos del receptor 5-ht6.
MX2013003736A (es) Novedosos agonistas del receptor de la proteina g 119.
MX2012007253A (es) Derivados triciclicos y sus usos y composiciones farmaceuticas.
PH12017500323B1 (en) P38 map kinase inhibiting indanyl urea compounds
GEP20156269B (en) New secondary 8-hydroxyquinoline-7- carboxamide derivatives
MX2010011767A (es) Derivados de benzocicloheptano y benzoxepina.